Top Markets
#1 DogBull DogBull +106.84%
#2 Siacoin Siacoin +59.07%
#3 ADO Protocol ADO Protocol +51.39%
#4 MarsCoin MarsCoin +49.76%
#5 The Bitcoin Bull The Bitcoin Bull +36.10%
#6 Nockchain Nockchain +21.09%
#7 Ontology Gas Ontology Gas +20.13%
#8 UnifAI Network UnifAI Network +19.77%
#9 Apertum Apertum +19.65%
#10 Useless Coin Useless Coin +16.31%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Rang in Aktien #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Aktienkurs
$9.50
Marktkapitalisierung
$357.67M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
92.70%
Land
US
Handel BioAge Labs Inc. (BIOA)

Kategorie

Healthcare
P/B-Verhältnis für BioAge Labs Inc. (BIOA)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von BioAge Labs Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für BioAge Labs Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.828 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.5116 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9942 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.2199 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH